Observational studyTransplantation2019

Use of Eculizumab for Active Antibody-mediated Rejection That Occurs Early Post-kidney Transplantation: A Consecutive Series of 15 Cases.

Ek Khoon Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.